These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3886413)

  • 1. The frequency of islet cell surface antibodies and antibody-dependent cell-mediated cytotoxicity (ADCC) of mononuclear cells in HLA-typed patients with high diabetes risk.
    Rjasanowski I; Michaelis D; Dietz H; Witt S; Köhler E; Knospe S
    Exp Clin Endocrinol; 1985 Feb; 85(1):70-4. PubMed ID: 3886413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.
    Dobersen MJ; Scharff JE; Ginsberg-Fellner F; Notkins AL
    N Engl J Med; 1980 Dec; 303(26):1493-8. PubMed ID: 7001237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
    Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet cell surface antibodies (ICSA) in subjects with a previous mumps infection--a prospective study over a 4 year period.
    Schulz B; Michaelis D; Hildmann W; Witt S; Hehmke B; Rjasanowski I
    Exp Clin Endocrinol; 1987 Aug; 90(1):62-70. PubMed ID: 3311781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.
    Köhler E; Knospe S; Hahn HJ; Roemer KG; Diamantstein T
    Exp Clin Endocrinol; 1989 May; 93(2-3):143-6. PubMed ID: 2673806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative estimation of islet cell surface antibodies in sera of patients with diabetes mellitus, using BK virus-induced insulinoma, rat islet or fish islet cells and 125I-antihuman IgG antibody.
    Negishi K; Kawazu S; Ishii J; Kanazawa Y
    J Clin Lab Immunol; 1986 Apr; 19(4):155-9. PubMed ID: 3014151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of islet cell surface antibodies in first-degree relatives of type 1 diabetic patients using rat insulinoma cells.
    Ziegler B; Heinke P; Schlosser M; Rjasanowski I; Michaelis D; Ziegler M
    Diabetes Res; 1989 Sep; 12(1):25-9. PubMed ID: 2698302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro.
    Kohnert KD; Hehmke B; Fält K; Ziegler M
    Biomed Biochim Acta; 1984; 43(5):663-73. PubMed ID: 6206850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats.
    Knospe S; Köhler E; Klöting I
    Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population survey of pancreatic islet cell antibodies.
    Rodger B; Whittingham S; Martin FI; Hawkins BR; Dawkins RL; Welborn TA
    Clin Exp Immunol; 1980 Jan; 39(1):125-9. PubMed ID: 6993063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia.
    Peters WH; Lester FT; Kohnert KD; Hildmann W
    Exp Clin Endocrinol; 1986 Aug; 87(3):326-32. PubMed ID: 3536536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
    Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of islet cell surface antibodies on neonatal rat pancreatic islet cells or isolated islets of Langerhans in vitro.
    Schröder D; Hehmke B; Kohnert KD; Fiebach H; Jenssen HL; Besch W
    Biomed Biochim Acta; 1985; 44(1):107-15. PubMed ID: 3888202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of anti-islet ADCC after manifestation of type-1 (insulin-dependent) diabetes.
    Köhler E; Knospe S; Besch W; Michaelis D; Rjasanowski I
    Exp Clin Endocrinol; 1989; 94(3):357-62. PubMed ID: 2698355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.